\section{References}
\cvreference{James E. Crowe Jr., MD}{Director, Vanderbilt Vaccine Center}{}{Vanderbilt University Medical Center}{(615) 343-8064}{James.Crowe@Vanderbilt.Edu}
\vspace{0.2cm}
\cvreference{Jens Meiler, PhD}{Full Professor of Chemistry and Pharmacology}{}{Vanderbilt University}{(615) 936-5662}{Jens.Meiler@Vanderbilt.Edu}
\vspace{0.2cm}
\cvreference{Natalie Thornburg, PhD}{Assistant Professor}{}{Center for Disease Control}{(404) 639-3797}{Nax@cdc.gov}
\vspace{0.2cm}
\cvreference{Josesph Jardine, PhD}{Head of Antibody Discovery}{}{Protein Innovation Institute}{(617) 651-8328}{jardine@crystal.harvard.edu}
\vspace{0.2cm}
\cvreference{Mark Hicar, MD, PhD}{Assistant Professor }{}{University at Buffalo, SUNY- Pediatric Infectious Diseases}{(716) 323-0150}{markhica@buffalo.edu}
\vspace{0.2cm}
\cvreference{Daniel Kulp, PhD}{Associate Professor, Vaccine \& Immunotherapy Center}{}{The Wistar Institute}{(215) 898-6587}{dwkulp@wistar.org}
\vspace{0.2cm}
\cvreference{Gopal Sapparapu, PhD, MBBS}{Therapeutic Antibody Lab Platform Technology Manager}{}{University of California, Los Angeles}{(281) 668-5124}{gopalsapparapu@gmail.com}
\vspace{0.2cm}
\cvreference{Benjamin Spiller, PhD}{Associate Professor of Pharmacology}{}{Vanderbilt University Medical Center}{(615) 322-6766}{benjamin.spiller@vanderbilt.edu}
\vspace{0.2cm}
\cvreference{Kent S. Gates, PhD}{Herman G. Schlundt Distinguished Professor of Chemistry}{}{University of Missouri}{(573) 882-8374}{GatesK@Missouri.Edu}
\vspace{0.2cm}